|
1
|
Itakura E, Yamamoto H, Oda Y and
Tsuneyoshi M: Detection and characterization of vascular
endothelial growth factors and their receptors in a series of
angiosarcomas. J Surg Oncol. 97:74–81. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clifford CA, Mackin AJ and Henry CJ:
Treatment of canine hemangiosarcoma: 2000 and beyond. J Vet Intern
Med. 14:479–485. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yonemaru K, Sakai H, Murakami M, Yanai T
and Masegi T: Expression of vascular endothelial growth factor,
basic fibroblast growth factor, and their receptors (flt-1, flk-1,
and flg-1) in canine vascular tumors. Vet Pathol. 43:971–980. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chappell WH, Steelman LS, Long JM, Kempf
RC, Abrams SL, Franklin RA, Bäsecke J, Stivala F, Donia F, Fagone
P, et al: Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors:
Rationale and importance to inhibiting these pathways in human
health. Oncotarget. 2:135–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
di Blasio L, Puliafito A, Gagliardi PA,
Comunanza V, Somale D, Chiaverina G, Bussolino F and Primo L:
PI3K/mTOR inhibition promotes the regression of experimental
vascular malformations driven by PIK3CA-activating mutations. Cell
Death Dis. 9:452018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matsumura I, Mizuki M and Kanakura Y:
Roles for deregulated receptor tyrosine kinases and their
downstream signaling molecules in hematologic malignancies. Cancer
Sci. 99:479–485. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arbiser JL, Weiss SW, Arbiser ZK, Bravo F,
Govindajaran B, Caceres-Rios H, Cotsonis G, Recavarren S, Swerlick
RA and Cohen C: Differential expression of active mitogen-activated
protein kinase in cutaneous endothelial neoplasms: Implications for
biologic behavior and response to therapy. J Am Acad Dermatol.
44:193–197. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kroll J and Waltenberger J: The vascular
endothelial growth factor receptor KDR activates multiple signal
transduction pathways in porcine aortic endothelial cells. J Biol
Chem. 272:32521–32527. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang X, Wang J, Deng X, Xiong F, Zhang S,
Gong Z, Li X, Cao K, Deng H, He Y, et al: The role of
microenvironment in tumor angiogenesis. J Exp Clin Cancer Res.
39:2042020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Blasio A, Wang J, Wang D, Varodayan FP,
Pomrenze MB, Miller J, Lee AM, McMahon T, Gyawali S, Wang HY, et
al: Novel small-molecule inhibitors of protein kinase C epsilon
reduce ethanol consumption in mice. Biol Psychiatry. 84:193–201.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Le Cras TD, Goines J, Lakes N, Pastura P,
Hammill AM, Adams DM and Boscolo E: Constitutively active PIK3CA
mutations are expressed by lymphatic and vascular endothelial cells
in capillary lymphatic venous malformation. Angiogenesis.
23:425–442. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dickerson EB, Thomas R, Fosmire SP,
Lamerato-Kozicki AR, Bianco SR, Wojcieszyn JW, Breen M, Helfand SC
and Modiano JF: Mutations of phosphatase and tensin homolog deleted
from chromosome 10 in canine hemangiosarcoma. Vet Pathol.
42:618–632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tate G, Suzuki T and Mitsuya T: Mutation
of the PTEN gene in a human hepatic angiosarcoma. Cancer Genet
Cytogenet. 178:160–162. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lahat G, Dhuka AR, Hallevi H, Xiao L, Zou
C, Smith KD, Phung TL, Pollock RE, Benjamin R, Hunt KK, et al:
Angiosarcoma: Clinical and molecular insights. Ann Surg.
251:1098–1106. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Murai A, Asa SA, Kodama A, Hirata A, Yanai
T and Sakai H: Constitutive phosphorylation of the
mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma
cell lines. BMC Vet Res. 8:1282012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tamburini BA, Trapp S, Phang TL, Schappa
JT, Hunter LE and Modiano JF: Gene expression profiles of sporadic
canine hemangiosarcoma are uniquely associated with breed. PLoS
One. 4:e55492009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lequarre AS, Andersson L, Andre C,
Fredholm M, Hitte C, Leeb T, Lohi H, Lindblad-Toh K and Georges M:
LUPA: A European initiative taking advantage of the canine genome
architecture for unravelling complex disorders in both human and
dogs. Vet J. 189:155–159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Espejo-Freire AP, Elliott A, Rosenberg A,
Costa PA, Barreto-Coelho P, Jonczak E, D'amato G, Subhawong T,
Arshad J, Diaz-Perez JA, et al: Genomic landscape of angiosarcoma:
A targeted and immunotherapy biomarker analysis. Cancers.
13:48162021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang G, Wu M, Maloneyhuss MA, Wojcik J,
Durham AC, Masson NJ and Royh DB: Actionable mutations in canine
hemangiosarcoma. PLoS One. 12:e01886672017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arafeh R and Samuels Y: PIK3CA in cancer:
The past 30 years. Semin Cancer Biol. 59:36–49. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
André F, Ciruelos E, Rubovszky G, Campone
M, Loibl S, Rugo HS, Iwata H, Conte P, Mayer IA, Kaufmanet K, et
al: Alpelisib for PIK3CA-mutated, hormone receptor-positive
advanced breast cancer. N Engl J Med. 380:1929–1940. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Misdorp W; Armed Forces Institute of
Pathology (U.S.); American Registry of Pathology; WHO Collaborating
Center for Worldwide Reference on Comparative Oncology, :
Histological classification of mammary tumors of the dog and the
cat. International Histological Classification of Tumors of
Domestic Animals. Vol 7. 2nd series. Armed Forces Institute of
Pathology in cooperation with the American Registry of Pathology
and the World Health Organization Collaborating Center for
Worldwide Reference on Comparative Oncology; Washington, DC:
1999
|
|
23
|
Uyama R, Nakagawa T, Hong SH, Mochizuki M,
Nishimura R and Sasaki N: Establishment of four pairs of canine
mammary tumour cell lines derived from primary and metastatic
origin and their E-cadherin expression. Vet Comp Oncol. 4:104–113.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghazanchaei A, Mansoori B, Mohammadi A,
Biglari A and Baradaran B: Restoration of miR-152 expression
suppresses cell proliferation, survival, and migration through
inhibition of AKT-ERK pathway in colorectal cancer. J Cell Physiol.
234:769–776. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Madsen RR, Vanhaesebroeck B and Semple RK:
Cancer-associated PIK3CA mutations in overgrowth disorders. Trends
Mol Med. 24:856–870. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim JH: PIK3CA mutations matter for cancer
in dogs. Res Vet Sci. 133:39–41. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ney JT, Froehner S, Roesler A, Buettner R
and Merkelbach-Bruse S: High-resolution melting analysis as a
sensitive prescreening diagnostic tool to detect KRAS, BRAF,
PIK3CA, and AKT1 mutations in formalin-fixed, paraffin-embedded
tissues. Arch Pathol Lab Med. 136:983–992. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Beca F, Krings G, Chen YY, Hosfield EM,
Vohra P, Sibley RK, Troxell ML, West RB, Allison KH and Bean GR:
Primary mammary angiosarcomas harbor frequent mutations in KDR and
PIK3CA and show evidence of distinct pathogenesis. Mod Pathol.
33:1518–1526. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang G, Wu M, Durham AC, Mason NJ and Roth
DB: Canine oncopanel: A capture-based, NGS platform for evaluating
the mutational landscape and detecting putative driver mutations in
canine cancers. Vet Comp Oncol. 20:91–101. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang J, Zhao W, Guo H, Fang Y, Stockman
SE, Bai S, Ng PK, Li Y, Yu Q, Lu Y, et al: AKT isoform-specific
expression and activation across cancer lineages. BMC Cancer.
18:7422018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo H, Gao M, Lu Y, Liang J, Lorenzi PL,
Bai S, Hawke DH, Li J, Dogruluk T, Scott KL, et al: Coordinate
phosphorylation of multiple residues on single AKT1 and AKT2
molecules. Oncogene. 33:3463–3472. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dillon RL, Marcotte R, Hennessy BT,
Woodgett JR, Mills GB and Muller WJ: Akt1 and akt2 play distinct
roles in the initiation and metastatic phases of mammary tumor
progression. Cancer Res. 69:5057–5064. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ihle MA, Fassunke J, König K, Grunewald I,
Schlaak M, Kreuzberg N, Tietze L, Schildhaus HU, Büttner R and
Merkelbach-Bruseet S: Comparison of high resolution melting
analysis, pyrosequencing, next generation sequencing and
immunohistochemistry to conventional Sanger sequencing for the
detection of p.V600E and non-p.V600E BRAF mutations. BMC Cancer.
14:132014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rascio F, Spadaccino F, Rocchetti MT,
Castellano G, Stallone G, Netti GS and Ranieri E: The pathogenic
role of PI3K/AKT pathway in cancer onset and drug resistance: An
updated review. Cancers. 13:39492021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fritsch C, Huang A, Chatenay-Rivauday C,
Schnell C, Reddy A, Liu M, Kauffmann A, Guthy D, Erdmann D, De
Pover A, et al: Characterization of the novel and specific PI3Kα
inhibitor NVP-BYL719 and development of the patient stratification
strategy for clinical trials. Mol Cancer Ther. 13:1117–1129. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Im KS, Graef AJ, Breen M, Lindblad-Toh K,
Modiano JF and Kim JH: Interactions between CXCR4 and CXCL12
promote cell migration and invasion of canine hemangiosarcoma. Vet
Comp Oncol. 15:315–327. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim JH, Graef AJ, Dickerson EB and Modiano
JF: Pathobiology of hemangiosarcoma in dogs: Research advances and
future perspectives. Vet Sci. 2:388–405. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim KH, Chung WS, Kim Y, Kim KS, Lee IS,
Park JY, Jeong HS, Na YC, Lee CH and Jang HJ: Transcriptomic
analysis reveals wound healing of morus alba root extract by
up-regulating keratin filament and CXCL12/CXCR4 signaling.
Phytother Res. 29:1251–1258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zuo J, Wen M, Li S, Lv X, Wang L, Ai X and
Lei M: Overexpression of CXCR4 promotes invasion and migration of
non-small cell lung cancer via EGFR and MMP-9. Oncol Lett.
14:7513–7521. 2017.PubMed/NCBI
|
